Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03434834 · ClinicalTrials.gov registry record · NA

OCT Pilot in Esophagus

A NA study of Barrett Esophagus, sponsored by Duke University.

Completed
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT03434834 is a NA study of Barrett Esophagus that has completed, run by Duke University. The registered enrollment target is 53 participants, below the 3,564-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03434834, a NA study of Barrett Esophagus, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study to test a newly developed optical coherence tomography (OCT) device to determine 1) whether adequate tissue contact can be attained to acquire high quality images, and 2) to identify if these images can discern whether the imaged tissue is squamous or Barrett's Esophagus (BE) epithelium.

Conditions Studied

Interventions

  • DEVICE optical coherence tomography

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2018-09-25
Est. Completion 2020-03-25
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03434834

The ClinicalTrials.gov registry entry for NCT03434834 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,564-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (99% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which optical coherence tomography is the first listed.

NCT03434834 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03434834 about?

NCT03434834 is a clinical study titled "OCT Pilot in Esophagus". This is a pilot study to test a newly developed optical coherence tomography (OCT) device to determine 1) whether adequate tissue contact can be attained to acquire high quality images, and 2) to identify if these images can discern whether the imaged tissue is squamous or Barrett's Esophagus (BE) e...

What is the current status of trial NCT03434834?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2018-09-25. Estimated completion is 2020-03-25.

What conditions does trial NCT03434834 study?

This clinical trial studies the following conditions: Barrett Esophagus.

What interventions are being tested in trial NCT03434834?

The interventions under investigation include: optical coherence tomography (DEVICE).

Who is sponsoring clinical trial NCT03434834?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03434834 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Barrett Esophagus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.